Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Slama

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
HIV Medicine|March 16, 2012
Body fat distribution in HIV-infected patients treated for 96 weeks with darunavir/ritonavir monotherapy versus darunavir/ritonavir plus nucleoside reverse transcriptase inhibitors: the MONOI-ANRS136 substudyM A Valantin, S Kolta, P Flandre, et al.
The Journal of Antimicrobial Chemotherapy|January 8, 2010
Switching the nucleoside reverse transcriptase inhibitor backbone to tenofovir disoproxil fumarate + emtricitabine promptly improves triglycerides and low-density lipoprotein cholesterol in dyslipidaemic patientsM A Valantin, R Bittar, P de Truchis, et al.
HIV Medicine|July 25, 2008
Viral efficacy maintained and safety parameters improved with a reduced dose of stavudine: a pilot studyH Ait-Mohand, M Bonmarchand, M Guiguet, et al.
Leukemia|April 9, 2010
Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasmsO Kosmider, V Gelsi-Boyer, L Slama, et al.
Medecine Et Maladies Infectieuses|May 25, 2013
Hepatitis B seroprevalence in HIV-infected patients consulting in a public day care unit in Bobo Dioulasso, Burkina FasoG Bado, P Penot, M D N'Diaye, et al.
The Journal of Antimicrobial Chemotherapy|December 14, 2011
Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 studyM A Valantin, S Lambert-Niclot, P Flandre, et al.
HIV Medicine|August 9, 2011
Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patientsS M E Vrouenraets, F W N M Wit, E Fernandez Garcia, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
HIV Medicine|March 16, 2012
Body fat distribution in HIV-infected patients treated for 96 weeks with darunavir/ritonavir monotherapy versus darunavir/ritonavir plus nucleoside reverse transcriptase inhibitors: the MONOI-ANRS136 substudyM A Valantin, S Kolta, P Flandre, et al.
The Journal of Antimicrobial Chemotherapy|January 8, 2010
Switching the nucleoside reverse transcriptase inhibitor backbone to tenofovir disoproxil fumarate + emtricitabine promptly improves triglycerides and low-density lipoprotein cholesterol in dyslipidaemic patientsM A Valantin, R Bittar, P de Truchis, et al.
HIV Medicine|July 25, 2008
Viral efficacy maintained and safety parameters improved with a reduced dose of stavudine: a pilot studyH Ait-Mohand, M Bonmarchand, M Guiguet, et al.
Leukemia|April 9, 2010
Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasmsO Kosmider, V Gelsi-Boyer, L Slama, et al.
Medecine Et Maladies Infectieuses|May 25, 2013
Hepatitis B seroprevalence in HIV-infected patients consulting in a public day care unit in Bobo Dioulasso, Burkina FasoG Bado, P Penot, M D N'Diaye, et al.
The Journal of Antimicrobial Chemotherapy|December 14, 2011
Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 studyM A Valantin, S Lambert-Niclot, P Flandre, et al.
HIV Medicine|August 9, 2011
Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patientsS M E Vrouenraets, F W N M Wit, E Fernandez Garcia, et al.
Pageof 7